期刊文献+

脂蛋白脂酶基因HindⅢ和PvuⅡ多态性与子痫前期相关性研究 被引量:1

Association of the lipoprotein lipase Hind Ⅲ and Pvu Ⅱ polymorphisms with preeclampsia
下载PDF
导出
摘要 目的:运用聚合酶链反应及限制性片段长度多态性(PCR-RFLP)方法研究脂蛋白脂酶(LPL)基因HindⅢ和PvuⅡ酶切位点多态性。从遗传学角度探讨其在子痫前期(PE)发生发展中的作用,并筛选易感基因,为PE的预防和治疗提供科学依据。方法:实验组按照乐杰主编《妇产科学》第6版标准,选取42例诊断子痫前期的患者,对照组选取50例年龄、孕周与实验组相近的正常孕妇。采用PCR-RFLP的方法,检测LPL基因PvuⅡ和HindⅢ酶切位点的多态性。结果:实验组LPL基因H+H+基因型33例(0.85),H+H-与H-H-基因型共6例(0.15),未出结果3例;对照组LPL基因H+H+基因型30例(0.60),H+H-与H-H-基因型共20例(0.40)。实验组等位基因H+71例(0.91),H-7例(0.09);对照组等位基因H+72例(0.72),H-28例(0.28)。基因型及等位基因分布频率组间比较,均P<0.05(基因型P=0.011,等位基因P=0.002),差异有统计学意义。LPL基因PvuⅡ酶切位点基因型(P+P+,P+P-,P-P-)及等位基因(P+,P-)分布频率在两组之间无明显差异(基因型P=0.627,等位基因P=0.941)。结论:LPL基因HindⅢ酶切位点多态性与PE的发生存在一定相关性,携带H+等位基因的孕妇可能更易发展成为PE。PvuⅡ酶切位点的基因多态性及等位基因P+与PE的发生无明显关联。 Objective: To study the relationship between lipoprotein lipase(LPL) gene Hind Ⅲ and Pvu Ⅱ polymorphism and the preeclampsia(PE) with polymerase chain reaction(PCR) and restriction fragment length polymorphism(RFLP) from the heredity perspective,screening the predisposing genes in order to provide a scientific base for preventing PE.Methods: LPL gene Pvu Ⅱ and Hind Ⅲ polymorphism were studied using PCR-RFLP in 42 PE and 50 healthy pregnant women with similar age and gestational weeks.Results: Results showed that 33 women in PE group had H+H+ and 6 women with H+H-and H-H-genotype.The control group had 30 women with H+H+ and 20 women with H+H-and H-H-genotype.The PE group had 71 allele of H+ and 7 of H-,while the control group had 72 of H+ and 28 of H-.There was a statistical significance both in the distribution of genotype and allelic frequency between the PE and control group(both the P0.05),while the Pvu Ⅱ polymorphism between the PE and control group had no statistical significance both in distribution of genotype and allelic frequency(both the P0.05).Conclusions: LPL gene Hind Ⅲ polymorphism is related with the occurance of PE.The H+ carrier may be more likely to develop PE.While the Pvu Ⅱ polymorphism and allele P+ have no significant relationship with PE.
出处 《东南大学学报(医学版)》 CAS 2010年第6期612-616,共5页 Journal of Southeast University(Medical Science Edition)
基金 江苏省高校自然科学基础研究项目(07KJD320145) 南京市医学科技发展项目(YKK08081)
关键词 子痫前期 脂蛋白脂酶 基因多态性 限制性片段长度多态性 聚合酶链反应 preeclampsia lipoprotein lipase gene polymorphism restriction fragment length polymerase chain reaction
  • 相关文献

参考文献20

  • 1乐杰.妇产科学[M].6版.北京:人民卫生出版社,2006:110.
  • 2MEAD J R,IRVINE S A,RAMJI D P.Lipoprotein lipase:structure,function,regulation,and role in disease[J].J Mol Med,2002,80(12):753-769.
  • 3WANG X L,McCREDIE R M,WILCKEN D E.Common DNA polymorphisms at the lipoprotein lipase gene:association with severity of coronary artery disease and diabetes[J].Circulation,1996,93(7):1339-1345.
  • 4徐友娣,殷慧蓉.妊娠高血压综合征与脂类、载脂蛋白、血浆蛋白代谢的关系[J].现代医学,2003,31(6):390-391. 被引量:7
  • 5郭海香,高眉扬.脂质代谢与妊娠高血压疾病的研究进展[J].中国妇幼健康研究,2006,17(2):106-108. 被引量:18
  • 6BAYHAN G,KOCYIGIT Y,ATAMER A,et al.Potential atherogenic role of lipids,lipoprotein(a) and lipid peroxidation in preeclampsia[J].Gynecol Endocrinol,2005,25(1):1-6.
  • 7ENQUOBAHRIE D A,WILLIAMS M A,BUTLER C L,et al.Mternal plasma lipid concentrations in early pregnancy and risk of preeclampsia[J].J Am Hypertens,2004,17(7):574-581.
  • 8MAGNUSSEN E B,VATTEN L J,LUND-NILSEN T I,et al.Prepregnancy cardiovascular risk factors as predictors of preeclampsia:population based cohort study[J].BMJ,2007,335(7627):978.
  • 9VAESSEN S F,SCHAAP F G,KUIVENHOVEN J A,et al.Apolipoprotein A-V,triglycerides and risk of coronary artery disease:the prospective Epic-Norfolk Population Study.[J].J Lipid Res,2006,47(9):2064-2070.
  • 10HUBEL C A,ROBERTS J M,FERRELL R E.Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene[J].Clin Genet,1999,56(4):289-296.

二级参考文献50

共引文献379

同被引文献15

  • 1林仲秋,狄文,马丁,等.妇产科学[M].北京:人民卫生出版社,2013:64-71.
  • 2ROIZ-HERNADEZ J, de CABELLO-MARTINEZ J. Human chorionic gonadotropin levels between 16 and 21 weeks of pregnancy and prediction of preeclampsia [ J ]. Int J Gyneeol Obstet, 2006,92 ( 2 ) : 101 - 105.
  • 3GOETZINGER K R, SINGLA A, GERKOWICZ S, et al. Pre- dicting the risk of preeclampsia between 11 and 13 weeks ges- tation by combining maternal characteristics and serum ana-lytes, PAPP- A and free fl- Heg [ J ]. Prenat Diagn, 2010,30 (12-13) :1138-1142.
  • 4ROBERTS J M, LAIN K Y. Recent insights into the pathogene- sis of pre- eclampsia [ J ]. Placenta,2002,23 ( 5 ) : 359- 372.
  • 5SEZER S D, KUCUK M, DOGER F K, et al. VEGF, PIGF and HIF- 1α in placentas of early- and late- onsetpre- eclamptic pa- tients [ J ]. Gynecol Endocrino1,2013,29 ( 8 ) :797- 800.
  • 6SUN S G, SHEN N,ZHENG Y H, et al. Expression of hypoxi- a-inducible factor-lalpha, vascular endothelial growth factor and sFh- 1 inpreeclampsia placenta [ J ]. Zhonghua Fu Chart Ke Za Zhi,2006,41 (7) :440-444.
  • 7VENKATESHA S,TOPORSIAN M, LAM C, et al. Soluble en- doglin contributes to the pathogenesis of preeclampsia [ J ]. Nat Med,2006,12(6) :642-649.
  • 8YINON Y, NEVO O, XU J, et al. Severe intrauterine growth restriction pregnancies have increased placental endugiin lev- els [ J ]. Am J Pathol, 2008,172 ( 1 ) : 77- 85.
  • 9MANNISTO T, MENDOLA P, VAARASMAKI M, et al. Ele- vated blood pressure in pregnancy and subsequent chronic disease risk [ J ]. Circulation,2013,127:681-690.
  • 10SU H,KAN Y W. Adeno-associated viral vector-delivered hy- poxia-inducible gene expression in ischemic hearts [ J ]. Methods Mol Biol,2007,366:331- 342.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部